| 1 |
35071967 | Differential effects of vascular endothelial growth factor on glycocalyx of endothelial and tumor cells and potential targets for tumor metastasis. | 2022 Mar |
2 |
| 2 |
33704312 | Synthetic heparan sulfate ligands for vascular endothelial growth factor to modulate angiogenesis. | 2021 Apr 11 |
1 |
| 3 |
33771558 | VEGF and VEGFR2 bind to similar pH-sensitive sites on fibronectin, exposed by heparin-mediated conformational changes. | 2021 Jan-Jun |
1 |
| 4 |
33920100 | Melanoma Associated Chitinase 3-Like 1 Promoted Endothelial Cell Activation and Immune Cell Recruitment. | 2021 Apr 10 |
1 |
| 5 |
32860852 | Small extracellular vesicle-bound vascular endothelial growth factor secreted by carcinoma-associated fibroblasts promotes angiogenesis in a bevacizumab-resistant manner. | 2020 Nov 1 |
1 |
| 6 |
27291973 | Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes. | 2016 Aug 20 |
1 |
| 7 |
27935954 | Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition. | 2016 |
1 |
| 8 |
24148804 | Heparin-dependent regulation of fibronectin matrix conformation. | 2014 Feb |
1 |
| 9 |
25399576 | The development of anti-angiogenic heparan sulfate oligosaccharides. | 2014 Dec |
2 |
| 10 |
23190312 | Age-related impairment of endothelial progenitor cell migration correlates with structural alterations of heparan sulfate proteoglycans. | 2013 Feb |
1 |
| 11 |
23734081 | Age-dependent alteration of intraocular soluble heparan sulfate levels and its implications for proliferative diabetic retinopathy. | 2013 |
2 |
| 12 |
23884416 | MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA). | 2013 Sep 6 |
2 |
| 13 |
22615183 | Synthesis of a heparan sulfate mimetic library targeting FGF and VEGF via click chemistry on a monosaccharide template. | 2012 Jul |
1 |
| 14 |
22927437 | Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. | 2012 Oct 19 |
4 |
| 15 |
20956519 | Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis. | 2011 Jan 7 |
1 |
| 16 |
20974861 | Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. | 2011 Jan 7 |
10 |
| 17 |
21221614 | Activation of heparanase by ultraviolet B irradiation leads to functional loss of basement membrane at the dermal-epidermal junction in human skin. | 2011 May |
1 |
| 18 |
21711246 | Signal transduction by vascular endothelial growth factor receptors. | 2011 Jul 15 |
1 |
| 19 |
20097882 | Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. | 2010 Mar 25 |
2 |
| 20 |
20524207 | Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity. | 2010 Oct 1 |
4 |
| 21 |
19422911 | Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis. | 2009 Jun |
1 |
| 22 |
18691882 | VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. | 2008 Sep |
3 |
| 23 |
16465447 | The role of VEGF receptors in angiogenesis; complex partnerships. | 2006 Mar |
1 |
| 24 |
16909199 | A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. | 2006 Sep |
2 |
| 25 |
16922507 | Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. | 2006 Aug 29 |
2 |
| 26 |
15952792 | Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165. | 2005 Jun 21 |
1 |
| 27 |
14570917 | pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release. | 2004 Jan 16 |
1 |
| 28 |
15260846 | Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas. | 2004 Aug |
4 |
| 29 |
12075747 | Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia. | 2002 May |
1 |
| 30 |
14517433 | Dual effects of heparin on VEGF binding to VEGF receptor-1 and transduction of biological responses. | 1999 |
1 |
| 31 |
9634701 | Solution structure of the heparin-binding domain of vascular endothelial growth factor. | 1998 May 15 |
1 |
| 32 |
9552515 | Naked cDNA encoding secreted proteins for intra-arterial and intramuscular gene transfer. | 1996 Sep |
1 |
| 33 |
7744769 | VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. | 1995 May 12 |
3 |
| 34 |
7522446 | Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors. | 1994 Sep 15 |
2 |
| 35 |
7681826 | Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin. | 1993 Apr 15 |
1 |
| 36 |
1464614 | Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. | 1992 Dec 25 |
1 |